Related Experiment Videos
Transluminal angioplasty versus surgical repair for stenosis of hemodialysis grafts. A randomized study
Insights
Surgical revision offers superior long-term patency for hemodialysis graft stenosis compared to transluminal angioplasty. While angioplasty has a role in specific cases, surgery is generally preferred for better outcomes.
Area of Science:
- Nephrology
- Vascular Surgery
- Interventional Radiology
Background:
- Vascular access stenosis is a common complication in hemodialysis patients, leading to access failure.
- Maintaining graft patency is crucial for effective hemodialysis treatment.
- Current treatment options include transluminal angioplasty and surgical revision.
Purpose of the Study:
- To compare the efficacy of transluminal angioplasty versus surgical revision for treating venous anastomosis stenosis in hemodialysis grafts.
- To evaluate long-term patency rates and cost-effectiveness of both treatment modalities.
Main Methods:
- A randomized controlled trial was conducted comparing transluminal angioplasty and surgical revision.
- Patients with stenosis at the venous end of hemodialysis grafts were enrolled.
- Patency rates and procedural costs were assessed over time.
Main Results:
- The median patency for the surgical revision group was 12 months, significantly longer than the 4 months for the transluminal angioplasty group (p < 0.01).
- Surgical revision was found to be slightly more cost-effective on average.
- A statistically significant difference in patency favored surgical intervention.
Conclusions:
- Surgical revision is the preferred method for achieving long-term patency in hemodialysis graft stenosis.
- Transluminal angioplasty may be considered in select cases or under special circumstances.
- Further research may explore optimizing angioplasty techniques or patient selection for improved outcomes.
Abstract:
A randomized study of transluminal angioplasty versus surgical revision for stenosis at the venous end of hemodialysis grafts was carried out. Median patency for the surgical group was 12 months versus only 4 months for the transluminal angioplasty group. This difference was statistically significant (p less than 0.01). In addition, the average cost for surgical revision was slightly less than that for transluminal angioplasty. Therefore, for long-term patency, surgical treatment is the method of choice, although under special circumstances there may still be a role for transluminal angioplasty.